on Adolore Biotherapeutics, Inc.
Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
Adolore BioTherapeutics, a biotechnology company focused on developing opioid-free gene therapy treatments for chronic pain, will present at the Virtual Investor Pitch Conference on June 17, 2024, at 10:00 AM ET. The event will feature Roelof Rongen, CEO of Adolore, who will deliver an "elevator pitch" and outline the company's upcoming milestones.
Participants will have the opportunity to submit questions live during the event. The webcast will be accessible on the event website, virtualinvestorco.com. A replay will be available two hours after the live presentation and will remain accessible for 90 days.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Adolore Biotherapeutics, Inc. news